Daniel Almeida Freitas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniel Almeida Freitas has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Cíntia Lacerda Ramos
Universidade Federal dos Vales do Jequitinhonha e Mucuri
2 shared publications - Paulo Henrique da Cruz Ferreira
Universidade Federal dos Vales do Jequitinhonha e Mucuri
2 shared publications - Vanessa Amaral Mendonça
Programa de Pós-Graduação em Reabilitação e Desempenho Funcional (PPGReab), Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM), Diamantina, Brazil
2 shared publications - Ana Cristina Rodrigues Lacerda
Programa de Pós-Graduação em Reabilitação e Desempenho Funcional (PPGReab), Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM), Diamantina, Brazil
1 shared publication - Ana Paula Pereira Bressani
Department of Food Science, Federal University of Lavras, Lavras, Brazil
1 shared publication - Cristiane Rocha Fagundes Moura
Department of Basic Sciences, Federal University of Vale of Jequitinhonha and Mucuri (UFVJM), Street MGT 367—Km 583, no 5000, Alto da Jacuba, Diamantina 39100-000, MG, Brazil
1 shared publication
Latest Publications
- Open Access
- 21 January 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (1) , 241
Species Identification, Virulence Factors, and Antifungal Resistance in Clinical Candida Isolates from ICU Patients
Candida spp. are important opportunistic human fungal pathogens. This study aimed to identify and characterize Candida spp. obtained from patients admitted to an Intensive Care Unit (ICU), focusing on virulence attributes and susceptibility to antifungal agents. A total of 131 isolates from oral and tracheobronchial secretions of adult ICU patients were evaluated. Phenotypic identification was performed using chromogenic culture media for Candida, followed by MALDI-TOF mass spectrometry, with representative isolates confirmed by ITS sequencing. Antifungal susceptibility to fluconazole, ketoconazole, and amphotericin B was determined only by the agar disk diffusion method, and virulence was assessed through esterase, DNase, protease, and hemolytic activity assays. C. albicans was the prevalent species, followed by C. tropicalis, C. krusei, C. glabrata, C. parapsilosis, C. dubliniensis, C. lusitaniae, and C. guilliermondii. Antifungal resistance rates reached 51.1% for fluconazole, 42.7% for ketoconazole, and 19.1% for amphotericin B, as determined by disk diffusion method. Overall, 64.9% of the isolates exhibited esterase activity, 18.3% DNase, 45.8% protease, and 67.2% exhibited hemolytic activity. Oral isolates were more frequent than tracheal isolates and demonstrated a higher prevalence of antifungal resistance and virulence traits. These findings underscore the epidemiological importance of characterizing Candida species in hospitals to better understand the yeast profile and to support adequate clinical management.
- 21 January 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (1) , 241
Open AccessSpecies Identification, Virulence Factors, and Antifungal Resistance in Clinical Candida Isolates from ICU Patients
Candida spp. are important opportunistic human fungal pathogens. This study aimed to identify and characterize Candida spp. obtained from patients admitted to an Intensive Care Unit (ICU), focusing on virulence attributes and susceptibility to antifungal agents. A total of 131 isolates from oral and tracheobronchial secretions of adult ICU patients were evaluated. Phenotypic identification was performed using chromogenic culture media for Candida, followed by MALDI-TOF mass spectrometry, with representative isolates confirmed by ITS sequencing. Antifungal susceptibility to fluconazole, ketoconazole, and amphotericin B was determined only by the agar disk diffusion method, and virulence was assessed through esterase, DNase, protease, and hemolytic activity assays. C. albicans was the prevalent species, followed by C. tropicalis, C. krusei, C. glabrata, C. parapsilosis, C. dubliniensis, C. lusitaniae, and C. guilliermondii. Antifungal resistance rates reached 51.1% for fluconazole, 42.7% for ketoconazole, and 19.1% for amphotericin B, as determined by disk diffusion method. Overall, 64.9% of the isolates exhibited esterase activity, 18.3% DNase, 45.8% protease, and 67.2% exhibited hemolytic activity. Oral isolates were more frequent than tracheal isolates and demonstrated a higher prevalence of antifungal resistance and virulence traits. These findings underscore the epidemiological importance of characterizing Candida species in hospitals to better understand the yeast profile and to support adequate clinical management.
- 27 January 2025
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 111 (3) , 116687
Factors associated with the presence of Candida spp. in the oral and tracheobronchial secretions of patients admitted to an adult intensive care unit
- 27 January 2025
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 111 (3) , 116687
Factors associated with the presence of Candida spp. in the oral and tracheobronchial secretions of patients admitted to an adult intensive care unit